124 related articles for article (PubMed ID: 38055341)
1. FBXW7 affects autophagy through MCL1 in oral squamous cell carcinoma.
Sun Y; Nie W; Qiu B; Yang Q; Zhao H
Oral Dis; 2023 Nov; 29(8):3259-3267. PubMed ID: 38055341
[TBL] [Abstract][Full Text] [Related]
2. FBXW7 promotes autophagy and inhibits proliferation of oral squamous cell carcinoma.
Qiu B; Sun Y; Nie W; Yang Q; Guo X
Immun Inflamm Dis; 2023 May; 11(5):e845. PubMed ID: 37249289
[TBL] [Abstract][Full Text] [Related]
3. FBXW7 Enhances Cisplatin-Induced Apoptosis in Oral Cancer Cell Lines.
Yang Q; Sun Y; Qiu B; Zhao H
Int Dent J; 2023 Oct; 73(5):620-627. PubMed ID: 36481094
[TBL] [Abstract][Full Text] [Related]
4. FBXW7 inhibited cell proliferation and invasion regulated by miR-27a through PI3K/AKT signaling pathway and epithelial-to-mesenchymal transition in oral squamous cell carcinoma.
Li C; Lin XF; Wang JN; Ren XS
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3701-3709. PubMed ID: 32329846
[TBL] [Abstract][Full Text] [Related]
5. MiR-223 promotes oral squamous cell carcinoma proliferation and migration by regulating FBXW7.
Jiang L; Lv L; Liu X; Jiang X; Yin Q; Hao Y; Xiao L
Cancer Biomark; 2019; 24(3):325-334. PubMed ID: 30883339
[TBL] [Abstract][Full Text] [Related]
6. FBXW7 expression affects the response to chemoradiotherapy and overall survival among patients with oral squamous cell carcinoma: A single-center retrospective study.
Arita H; Nagata M; Yoshida R; Matsuoka Y; Hirosue A; Kawahara K; Sakata J; Nakashima H; Kojima T; Toya R; Murakami R; Hiraki A; Shinohara M; Nakayama H
Tumour Biol; 2017 Oct; 39(10):1010428317731771. PubMed ID: 29072128
[TBL] [Abstract][Full Text] [Related]
7. Promotive effects of HOXA10 antisense RNA on the stemness of oral squamous cell carcinoma stem cells through a microRNA-29a/MCL-1/phosphatidyl inositol 3-kinase/protein kinase B axis.
Wang D
Arch Oral Biol; 2021 Jun; 126():105114. PubMed ID: 33831733
[TBL] [Abstract][Full Text] [Related]
8. Loss of FBXW7 and accumulation of MCL1 and PLK1 promote paclitaxel resistance in breast cancer.
Gasca J; Flores ML; Giráldez S; Ruiz-Borrego M; Tortolero M; Romero F; Japón MA; Sáez C
Oncotarget; 2016 Aug; 7(33):52751-52765. PubMed ID: 27409838
[TBL] [Abstract][Full Text] [Related]
9. Puerarin Suppresses Glycolysis and Increases Cisplatin Chemosensitivity in Oral Squamous Cell Carcinoma
Cai Y; Gao Q; Meng JH; Chen L
Nutr Cancer; 2023; 75(3):1028-1037. PubMed ID: 36718661
[TBL] [Abstract][Full Text] [Related]
10. FBXW7 modulates malignant potential and cisplatin-induced apoptosis in cholangiocarcinoma through NOTCH1 and MCL1.
Mori A; Masuda K; Ohtsuka H; Shijo M; Ariake K; Fukase K; Sakata N; Mizuma M; Morikawa T; Hayashi H; Nakagawa K; Motoi F; Naitoh T; Fujishima F; Unno M
Cancer Sci; 2018 Dec; 109(12):3883-3895. PubMed ID: 30302867
[TBL] [Abstract][Full Text] [Related]
11. Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma.
Lv Z; Wu X; Cao W; Shen Z; Wang L; Xie F; Zhang J; Ji T; Yan M; Chen W
J Exp Clin Cancer Res; 2014 Dec; 33(1):100. PubMed ID: 25539663
[TBL] [Abstract][Full Text] [Related]
12. LINC00629, a KLF10-responsive lncRNA, promotes the anticancer effects of apigenin by decreasing Mcl1 stability in oral squamous cell carcinoma.
Shi C; Ma C; Ren C; Li N; Liu X; Zhang Y; Wang Y; Li X; Lv P; Han C; Li X
Aging (Albany NY); 2022 Nov; 14(22):9149-9166. PubMed ID: 36445338
[TBL] [Abstract][Full Text] [Related]
13. A Five-mRNA Expression Signature to Predict Survival in Oral Squamous Cell Carcinoma by Integrated Bioinformatic Analyses.
Guo H; Li C; Su X; Huang X
Genet Test Mol Biomarkers; 2021 Aug; 25(8):517-527. PubMed ID: 34406843
[No Abstract] [Full Text] [Related]
14. Overexpression of lncRNA HOXA-AS2 promotes the progression of oral squamous cell carcinoma by mediating SNX5 expression.
Li Z
BMC Mol Cell Biol; 2022 Dec; 23(1):59. PubMed ID: 36528556
[TBL] [Abstract][Full Text] [Related]
15. Nitidine chloride represses Mcl-1 protein via lysosomal degradation in oral squamous cell carcinoma.
Yang IH; Jung W; Kim LH; Shin JA; Cho NP; Hong SD; Hong KO; Cho SD
J Oral Pathol Med; 2018 Oct; 47(9):823-829. PubMed ID: 29924888
[TBL] [Abstract][Full Text] [Related]
16. Isoform specific FBXW7 mediates NOTCH1 Abruptex mutation C1133Y deregulation in oral squamous cell carcinoma.
Zheng Y; Song A; Wang C; Zhang W; Liang D; Ding X; Li G; Zhang H; Zhang W; Du Y; Zhou J; Wu H; Wu Y; Song X
Cell Death Dis; 2020 Aug; 11(8):615. PubMed ID: 32792479
[TBL] [Abstract][Full Text] [Related]
17. MARCH1 silencing suppresses growth of oral squamous cell carcinoma through regulation of PHLPP2.
Liu L; Guo B; Han Y; Xu S; Liu S
Clin Transl Oncol; 2022 Jul; 24(7):1311-1321. PubMed ID: 35122633
[TBL] [Abstract][Full Text] [Related]
18. Immunity-related long noncoding RNA WDFY3-AS2 inhibited cell proliferation and metastasis through Wnt/β-catenin signaling in oral squamous cell carcinoma.
Lin X; Ding JM; Zheng XZ; Chen JG
Arch Oral Biol; 2023 Mar; 147():105625. PubMed ID: 36657277
[TBL] [Abstract][Full Text] [Related]
19. HMG20A was identified as a key enhancer driver associated with DNA damage repair in oral squamous cell carcinomas.
Na L; Meijie Z; Wenjing Z; Bing Z; Yanhao D; Shanshan L; Yongle Q
BMC Oral Health; 2022 Nov; 22(1):473. PubMed ID: 36335317
[TBL] [Abstract][Full Text] [Related]
20. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]